EVEREST | A clinical trial for liver transplant recipients

Developing, funding and conducting clinical trials in immune tolerance

Are you or a loved one a LIVER TRANSPLANT RECIPIENT?

A clinical trial evaluating a new drug combination to reduce or stop anti-rejection medications in people with liver transplants.

If you are an adult 1 to 10 years post liver transplant you may be eligible for the EVEREST Study.

The Everest study is being conducted at three US clinical sites.